Immune Mechanisms of Corneal Allograft Rejection

REFERENCES

• Kissam R. Ceratoplastice in man. New York Journal of Medicine 1844; 2: 281–289
   Google Scholar
• May C H. Transplantation of a rabbit's eye into the human orbit. Arch Ophthalmol. 1887; 16: 47–53
   Google Scholar
• Zirm E. Eine erfolgreiche totale Keratoplastik. Albrecht von Graefes Arch Ophthalmol. 1906; 64: 580–593
   Google Scholar
• Darlington J K, Adrean S D, Schwab I R. Trends of penetrating keratoplasty in the United States from 1980 to 2004. Ophthalmology 2006; 113: 2171–2175
   PubMed Web of Science ®Google Scholar
• Group CCTSR. The collaborative corneal transplantation studies (CCTS). Effectiveness of histocompatibility matching in high-risk corneal transplantation. Arch Ophthalmol 1992; 110: 1392–1403
   PubMedGoogle Scholar
• Billingham R E, Krohn P L, Medawar P B. Effect of cortisone on survival of skin homografts in rabbits. Br Med J. 1951; 1: 1157–1163
   PubMed Web of Science ®Google Scholar
• Niederkorn J Y. The immune privilege of corneal allografts. Transplantation 1999; 67: 1503–1508
   PubMed Web of Science ®Google Scholar
• Niederkorn J Y. Mechanisms of corneal graft rejection: The sixth annual Thygeson Lecture, presented at the Ocular Microbiology and Immunology Group meeting, October 21, 2000. Cornea 2001; 20: 675–679
   PubMed Web of Science ®Google Scholar
• Coster D J, Williams K A. The impact of corneal allograft rejection on the long-term outcome of corneal transplantation. Am J Ophthalmol. 2005; 140: 1112–1122
   PubMed Web of Science ®Google Scholar
• Maumenee A. The influence of donor-recipient sensitization on corneal grafts. Am J Ophthalmol. 1951; 34: 142–152
   PubMed Web of Science ®Google Scholar
• Khodadoust A A, Silverstein A M. Transplantation and rejection of individual cell layers of the cornea. Invest Ophthalmol. 1969; 8: 180–195
   PubMedGoogle Scholar
• Khodadoust A A, Silverstein A M. Induction of corneal graft rejection by passive cell transfer. Invest Ophthalmol. 1976; 15: 89–95
   PubMedGoogle Scholar
• Pepose J S, Nestor M S, Gardner K M, Foos R Y, Pettit T H. Composition of cellular infiltrates in rejected human corneal allografts. Graefes Arch Clin Exp Ophthalmol. 1985; 222: 128–133
   PubMed Web of Science ®Google Scholar
• Williams K A, Coster D J. Penetrating corneal transplantation in the inbred rat: A new model. Invest Ophthalmol Vis Sci. 1985; 26: 23–30
   PubMed Web of Science ®Google Scholar
• She S C, Steahly L P, Moticka E J. A method for performing full-thickness, orthotopic, penetrating keratoplasty in the mouse. Ophthalmic Surg. 1990; 21: 781–785
   PubMedGoogle Scholar
• Ayliffe W, Alam Y, Bell E B, McLeod D, Hutchinson I V. Prolongation of rat corneal graft survival by treatment with anti-CD4 monoclonal antibody. Br J Ophthalmol. 1992; 76: 602–606
   PubMed Web of Science ®Google Scholar
• He Y G, Ross J, Niederkorn J Y. Promotion of murine orthotopic corneal allograft survival by systemic administration of anti-CD4 monoclonal antibody. Invest Ophthalmol Vis Sci. 1991; 32: 2723–2728
   PubMed Web of Science ®Google Scholar
• Niederkorn J Y, Stevens C, Mellon J, Mayhew E. CD4+ T-cell-independent rejection of corneal allografts. Transplantation 2006; 81: 1171–1178
   PubMed Web of Science ®Google Scholar
• Yamada J, Kurimoto I, Streilein J W. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice. Invest Ophthalmol Vis Sci. 1999; 40: 2614–2621
   PubMed Web of Science ®Google Scholar
• Niederkorn J Y, Mellon J. Anterior chamber-associated immune deviation promotes corneal allograft survival. Invest Ophthalmol Vis Sci. 1996; 37: 2700–2707
   PubMed Web of Science ®Google Scholar
• She S C, Moticka E J. Ability of intracamerally inoculated B- and T-cell enriched allogeneic lymphocytes to enhance corneal allograft survival. Int Ophthalmol. 1993; 17: 1–7
   PubMed Web of Science ®Google Scholar
• She S C, Steahly L P, Moticka E J. Intracameral injection of allogeneic lymphocytes enhances corneal graft survival. Invest Ophthalmol Vis Sci. 1990; 31: 1950–1956
   PubMed Web of Science ®Google Scholar
• Sonoda Y, Streilein J W. Orthotopic corneal transplantation in mice—Evidence that the immunogenetic rules of rejection do not apply. Transplantation 1992; 54: 694–704
   PubMed Web of Science ®Google Scholar
• Lowin B, Hahne M, Mattmann C, Tschopp J. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 1994; 370: 650–652
   PubMed Web of Science ®Google Scholar
• Williams N S, Engelhard V H. Perforin-dependent cytotoxic activity and lymphokine secretion by CD4+ T cells are regulated by CD8+ T cells. J Immunol. 1997; 159: 2091–2099
   PubMed Web of Science ®Google Scholar
• Hegde S, Niederkorn J Y. The role of cytotoxic T lymphocytes in corneal allograft rejection. Invest Ophthalmol Vis Sci. 2000; 41: 3341–3347
   PubMed Web of Science ®Google Scholar
• Hegde S, Beauregard C, Mayhew E, Niederkorn J Y. CD4(+) T-cell-mediated mechanisms of corneal allograft rejection: Role of Fas-induced apoptosis. Transplantation 2005; 79: 23–31
   PubMed Web of Science ®Google Scholar
• Stuart P M, Yin X, Plambeck S, Pan F, Ferguson T A. The role of Fas ligand as an effector molecule in corneal graft rejection. Eur J Immunol. 2005; 35: 2591–2597
   PubMed Web of Science ®Google Scholar
• Torres P F, De Vos A F, van der Gaag R, Martins B, Kijlstra A. Cytokine mRNA expression during experimental corneal allograft rejection. Exp Eye Res. 1996; 63: 453–461
   PubMed Web of Science ®Google Scholar
• Zhu S, Dekaris I, Duncker G, Dana M R. Early expression of proinflammatory cytokines interleukin-1 and tumor necrosis factor-alpha after corneal transplantation. J Interferon Cytokine Res. 1999; 19: 661–669
   PubMed Web of Science ®Google Scholar
• Pleyer U, Milani J K, Ruckert D, Rieck P, Mondino B J. Determinations of serum tumor necrosis factor alpha in corneal allografts. Ocul Immunol Inflamm. 1997; 5: 149–155
   PubMed Web of Science ®Google Scholar
• Rayner S A, King W J, Comer R M, et al. Local bioactive tumour necrosis factor (TNF) in corneal allotransplantation. Clin Exp Immunol 2000; 122: 109–116
   PubMed Web of Science ®Google Scholar
• Yamada J, Streilein J W, Dana M R. Role of tumor necrosis factor receptors TNFR-I (P55) and TNFR-II (P75) in corneal transplantation. Transplantation 1999; 68: 944–949
   PubMed Web of Science ®Google Scholar
• Niederkorn J Y, Mayhew E, Mellon J, Hegde S. Role of tumor necrosis factor receptor expression in anterior chamber-associated immune deviation (ACAID) and corneal allograft survival. Invest Ophthalmol Vis Sci. 2004; 45: 2674–2681
   PubMed Web of Science ®Google Scholar
• Callanan D, Peeler J, Niederkorn J Y. Characteristics of rejection of orthotopic corneal allografts in the rat. Transplantation 1988; 45: 437–443
   PubMed Web of Science ®Google Scholar
• Callanan D G, Luckenbach M W, Fischer B J, Peeler J S, Niederkorn J Y. Histopathology of rejected orthotopic corneal grafts in the rat. Invest Ophthalmol Vis Sci. 1989; 30: 413–424
   PubMed Web of Science ®Google Scholar
• Roelen D L, van Beelen E, van Bree S P, van Rood J J, Volker-Dieben H J, Claas F H. The presence of activated donor HLA class I-reactive T lymphocytes is associated with rejection of corneal grafts. Transplantation 1995; 59: 1039–1042
   PubMed Web of Science ®Google Scholar
• Yamada J, Ksander B R, Streilein J W. Cytotoxic T cells play no essential role in acute rejection of orthotopic corneal allografts in mice. Invest Ophthalmol Vis Sci. 2001; 42: 386–392
   PubMed Web of Science ®Google Scholar
• Ksander B R, Sano Y, Streilein J W. Role of donor-specific cytotoxic T cells in rejection of corneal allografts in normal and high-risk eyes. Transpl Immunol. 1996; 4: 49–52
   PubMedGoogle Scholar
• Niederkorn J Y, Stevens C, Mellon J, Mayhew E. Differential roles of CD8+ and CD8– T lymphocytes in corneal allograft rejection in ‘high-risk’ hosts. Am J Transplant. 2006; 6: 705–713
   PubMed Web of Science ®Google Scholar
• Bishop D K, Chan Wood S, Eichwald E J, Orosz C G. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions. J Immunol. 2001; 166: 3248–3255
   PubMed Web of Science ®Google Scholar
• Jones N D, Carvalho-Gaspar M, Luo S, Brook M O, Martin L, Wood K J. Effector and memory CD8+ T cells can be generated in response to alloantigen independently of CD4+ T cell help. J Immunol. 2006; 176: 2316–2323
   PubMed Web of Science ®Google Scholar
• Trambley J, Bingaman A W, Lin A, et al. Asialo GM1(+) CD8(+) T cells play a critical role in costimulation blockade-resistant allograft rejection. J Clin Invest 1999; 104: 1715–1722
   PubMed Web of Science ®Google Scholar
• Zhai Y, Meng L, Busuttil R W, Sayegh M H, Kupiec-Weglinski J W. Activation of alloreactive CD8+ T cells operates via CD4-dependent and CD4-independent mechanisms and is CD154 blockade sensitive. J Immunol. 2003; 170: 3024–3028
   PubMed Web of Science ®Google Scholar
• Ehlers N, Olsen T, Johnsen H E. Corneal graft rejection probably mediated by antibodies. Acta Ophthalmol (Copenh). 1981; 59: 119–125
   PubMed Web of Science ®Google Scholar
• Hahn A B, Foulks G N, Enger C, et al. The association of lymphocytotoxic antibodies with corneal allograft rejection in high risk patients. The Collaborative Corneal Transplantation Studies Research Group. Transplantation 1995; 59: 21–27
   PubMed Web of Science ®Google Scholar
• Jager M J, Vos A, Pasmans S, Hoekzema R, Broersma L, van der Gaag R. Circulating cornea-specific antibodies in corneal disease and cornea transplantation. Graefes Arch Clin Exp Ophthalmol. 1994; 232: 82–86
   PubMed Web of Science ®Google Scholar
• Roy R, Boisjoly H M, Wagner E, et al. Pretransplant and posttransplant antibodies in human corneal transplantation. Transplantation 1992; 54: 463–467
   PubMed Web of Science ®Google Scholar
• van Dorp G, Volker-Dieben H J, van Leeuwen A, Kok-Van Alphen C C, van Rood J J. Major histocompatibility complex or HL-A antibodies in patients with a rejection reaction [proceedings]. Ophthalmologica 1977; 175: 42
   PubMed Web of Science ®Google Scholar
• Group TCCTSR. The collaborative corneal transplantation studies (CCTS). Effectiveness of histocompatibility matching in high-risk corneal transplantation. The Collaborative Corneal Transplantation Studies Research Group. Arch Ophthalmol 1992; 110: 1392–1403
   PubMedGoogle Scholar
• Salisbury J D, Gebhardt B M. Blood group antigens on human corneal cells demonstrated by immunoperoxidase staining. Am J Ophthalmol. 1981; 91: 46–50
   PubMed Web of Science ®Google Scholar
• Grunnet N, Kristensen T, Kissmeyer-Nielsen F, Ehlers N. Occurrence of lymphocytotoxic lymphocytes and antibodies after corneal transplantation. Acta Ophthalmol (Copenh). 1976; 54: 167–173
   PubMed Web of Science ®Google Scholar
• Goslings W R, Yamada J, Dana M R, et al. Corneal transplantation in antibody-deficient hosts. Invest Ophthalmol Vis Sci 1999; 40: 250–253
   PubMed Web of Science ®Google Scholar
• Hegde S, Mellon J K, Hargrave S L, Niederkorn J Y. Effect of alloantibodies on corneal allograft survival. Invest Ophthalmol Vis Sci. 2002; 43: 1012–1018
   PubMed Web of Science ®Google Scholar
• Holan V, Vitova A, Krulova M, et al. Susceptibility of corneal allografts and xenografts to antibody-mediated rejection. Immunol Lett 2005; 100: 211–213
   PubMed Web of Science ®Google Scholar
• Bora N S, Gobleman C L, Atkinson J P, Pepose J S, Kaplan H J. Differential expression of the complement regulatory proteins in the human eye. Invest Ophthalmol Vis Sci. 1993; 34: 3579–3584
   PubMed Web of Science ®Google Scholar
• Lass J H, Walter E I, Burris T E, et al. Expression of two molecular forms of the complement decay-accelerating factor in the eye and lacrimal gland. Invest Ophthalmol Vis Sci 1990; 31: 1136–1148
   PubMed Web of Science ®Google Scholar
• Goslings W R, Prodeus A P, Streilein J W, Carroll M C, Jager M J, Taylor A W. A small molecular weight factor in aqueous humor acts on C1q to prevent antibody-dependent complement activation. Invest Ophthalmol Vis Sci. 1998; 39: 989–995
   PubMed Web of Science ®Google Scholar
• Hargrave S L, Mayhew E, Hegde S, Niederkorn J. Are corneal cells susceptible to antibody-mediated killing in corneal allograft rejection?. Transpl Immunol. 2003; 11: 79–89
   PubMed Web of Science ®Google Scholar
• Nickerson P, Steurer W, Steiger J, Zheng X, Steele A W, Strom T B. Cytokines and the Th1/Th2 paradigm in transplantation. Curr Opin Immunol. 1994; 6: 757–764
   PubMed Web of Science ®Google Scholar
• Mosmann T R, Cherwinski H, Bond M W, Giedlin M A, Coffman R L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986; 136: 2348–2357
   PubMed Web of Science ®Google Scholar
• Yamada J, Yoshida M, Taylor A W, Streilein J W. Mice with Th2-biased immune systems accept orthotopic corneal allografts placed in “high risk” eyes. J Immunol. 1999; 162: 5247–5255
   PubMed Web of Science ®Google Scholar
• Le Moine A, Flamand V, Demoor F X, et al. Critical roles for IL-4, IL-5, and eosinophils in chronic skin allograft rejection. J Clin Invest 1999; 103: 1659–1667
   PubMed Web of Science ®Google Scholar
• Piccotti J R, Chan S Y, Goodman R E, Magram J, Eichwald E J, Bishop D K. IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection. Evidence against a dominant protective role for T helper 2 cytokines in alloimmunity. J Immunol. 1996; 157: 1951–1957
   PubMed Web of Science ®Google Scholar
• VanBuskirk A M, Wakely M E, Orosz C G. Transfusion of polarized TH2-like cell populations into SCID mouse cardiac allograft recipients results in acute allograft rejection. Transplantation. 1996; 62: 229–238
   PubMed Web of Science ®Google Scholar
• Hargrave S L, Hay C, Mellon J, Mayhew E, Niederkorn J Y. Fate of MHC-matched corneal allografts in Th1-deficient hosts. Invest Ophthalmol Vis Sci 2004; 45: 1188–1193
   PubMed Web of Science ®Google Scholar
• Easty D, Entwistle C, Funk A, Witcher J. Herpes simplex keratitis and keratoconus in the atopic patient. A clinical and immunological study. Trans Ophthalmol Soc UK 1975; 95: 267–276
   PubMedGoogle Scholar
• Ghoraishi M, Akova Y A, Tugal-Tutkun I, Foster C S. Penetrating keratoplasty in atopic keratoconjunctivitis. Cornea. 1995; 14: 610–613
   PubMed Web of Science ®Google Scholar
• Hargrave S, Chu Y, Mendelblatt D, Mayhew E, Niederkorn J. Preliminary findings in corneal allograft rejection in patients with keratoconus. Am J Ophthalmol. 2003; 135: 452–460
   PubMed Web of Science ®Google Scholar
• Lyons C J, Dart J K, Aclimandos W A, Lightman S, Buckley R J. Sclerokeratitis after keratoplasty in atopy. Ophthalmology. 1990; 97: 729–733
   PubMed Web of Science ®Google Scholar
• Harrison R J, Klouda P T, Easty D L, Manku M, Charles J, Stewart C M. Association between keratoconus and atopy. Br J Ophthalmol. 1989; 73: 816–822
   PubMed Web of Science ®Google Scholar
• Beauregard C, Stevens C, Mayhew E, Niederkorn J Y. Cutting edge: Atopy promotes Th2 responses to alloantigens and increases the incidence and tempo of corneal allograft rejection. J Immunol. 2005; 174: 6577–6581
   PubMed Web of Science ®Google Scholar
• Flynn T H, Ohbayashi M, Ikeda Y, Ono S J, Larkin D F. Effect of allergic conjunctival inflammation on the allogeneic response to donor cornea. Invest Ophthalmol Vis Sci. 2007; 48: 4044–4049
   PubMed Web of Science ®Google Scholar
• Hargrave S L, Mellon J, Niederkorn J. MHC matching improves corneal allograft survival in mice with Th2-immune bias. Transplant Proc. 2002; 34: 3413–3415
   PubMed Web of Science ®Google Scholar
• Matesic D, Valujskikh A, Pearlman E, Higgins A W, Gilliam A C, Heeger P S. Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells. J Immunol. 1998; 161: 5236–5244
   PubMed Web of Science ®Google Scholar
• Abbas A K, Murphy K M, Sher A. Functional diversity of helper T lymphocytes. Nature. 1996; 383: 787–793
   PubMed Web of Science ®Google Scholar
• Dvorak H F, Galli S J, Dvorak A M. Cellular and vascular manifestations of cell-mediated immunity. Hum Pathol. 1986; 17: 122–137
   PubMed Web of Science ®Google Scholar
• Larkin D F, Alexander R A, Cree I A. Infiltrating inflammatory cell phenotypes and apoptosis in rejected human corneal allografts. Eye. 1997; 11: 68–74
   PubMed Web of Science ®Google Scholar
• Larkin D F, Calder V L, Lightman S L. Identification and characterization of cells infiltrating the graft and aqueous humor in rat corneal allograft rejection. Clin Exp Immunol. 1997; 107: 381–391
   PubMed Web of Science ®Google Scholar
• Williams K A, White M A, Ash J K, Coster D J. Leukocytes in the graft bed associated with corneal graft failure. Analysis by immunohistology and actuarial graft survival. Ophthalmology 1989; 96: 38–44
   PubMed Web of Science ®Google Scholar
• Brissette-Storkus C S, Reynolds S M, Lepisto A J, Hendricks R L. Identification of a novel macrophage population in the normal mouse corneal stroma. Invest Ophthalmol Vis Sci. 2002; 43: 2264–2271
   PubMed Web of Science ®Google Scholar
• Yamagami S, Ebihara N, Usui T, Yokoo S, Amano S. Bone marrow-derived cells in normal human corneal stroma. Arch Ophthalmol. 2006; 124: 62–69
   PubMedGoogle Scholar
• Yamamoto N, Einaga-Naito K, Kuriyama M, Kawada Y, Yoshida R. Cellular basis of skin allograft rejection in mice: Specific lysis of allogeneic skin components by non-T cells. Transplantation. 1998; 65: 818–825
   PubMed Web of Science ®Google Scholar
• Slegers T P, Torres P F, Broersma L, van Rooijen N, van Rij G, van der Gaag R. Effect of macrophage depletion on immune effector mechanisms during corneal allograft rejection in rats. Invest Ophthalmol Vis Sci. 2000; 41: 2239–2247
   PubMed Web of Science ®Google Scholar
• Nair S, Buiting A M, Rouse R J, Van Rooijen N, Huang L, Rouse B T. Role of macrophages and dendritic cells in primary cytotoxic T lymphocyte responses. Int Immunol. 1995; 7: 679–688
   PubMed Web of Science ®Google Scholar
• Niederkorn J Y. The immunology of corneal transplantation. Dev Ophthalmol. 1999; 30: 129–140
   PubMedGoogle Scholar
• Niederkorn J Y. Immunology and immunomodulation of corneal transplantation. Intern Rev Immunol. 2002; 21: 173–196
   PubMedGoogle Scholar
• Niederkorn J Y. The immune privilege of corneal grafts. J Leukoc Biol. 2003; 74: 167–171
   PubMed Web of Science ®Google Scholar
• Claerhout I, Kestelyn P, Debacker V, Beele H, Leclercq G. Role of natural killer cells in the rejection process of corneal allografts in rats. Transplantation. 2004; 77: 676–682
   PubMed Web of Science ®Google Scholar
• Mayer K, Reinhard T, Reis A, Niehues T, Claas F H, Sundmacher R. Differential contribution of natural killer cells to corneal graft rejection in 3-week-old versus mature rats. Transplantation. 2003; 76: 578–582
   PubMed Web of Science ®Google Scholar
• Ljunggren H G, Karre K. In search of the ‘missing self’: MHC molecules and NK cell recognition. Immunol Today. 1990; 11: 237–244
   PubMedGoogle Scholar
• Kitchens W H, Uehara S, Chase C M, Colvin R B, Russell P S, Madsen J C. The changing role of natural killer cells in solid organ rejection and tolerance. Transplantation. 2006; 81: 811–817
   PubMed Web of Science ®Google Scholar
• LaRosa D F, Rahman A H, Turka L A. The innate immune system in allograft rejection and tolerance. J Immunol 2007; 178: 7503–7509
   PubMed Web of Science ®Google Scholar
• Maier S, Tertilt C, Chambron N, et al. Inhibition of natural killer cells results in acceptance of cardiac allografts in CD28–/– mice. Nat Med. 2001; 7: 557–562
   PubMed Web of Science ®Google Scholar
• McNerney M E, Lee K M, Zhou P, et al. Role of natural killer cell subsets in cardiac allograft rejection. Am J Transplant 2006; 6: 505–513
   PubMed Web of Science ®Google Scholar
• Brierly S C, Izquierdo L, Jr, Mannis M J. Penetrating keratoplasty for keratoconus. Cornea. 2000; 19: 329–332
   PubMed Web of Science ®Google Scholar
• Kirkness C M, Ezra E, Rice N S, Steele A D. The success and survival of repeat corneal grafts. Eye 1990; 4: 58–64, (Pt. 1)
   PubMed Web of Science ®Google Scholar
• Shimmura S, Tsubota K. Deep anterior lamellar keratoplasty. Curr Opin Ophthalmol. 2006; 17: 349–355
   PubMed Web of Science ®Google Scholar
• Sugita J, Kondo J. Deep lamellar keratoplasty with complete removal of pathological stroma for vision improvement. Br J Ophthalmol. 1997; 81: 184–188
   PubMed Web of Science ®Google Scholar
• Watson S L, Tuft S J, Dart J K. Patterns of rejection after deep lamellar keratoplasty. Ophthalmology. 2006; 113: 556–560
   PubMed Web of Science ®Google Scholar
• Panda A, Vanathi M, Kumar A, Dash Y, Priya S. Corneal graft rejection. Surv Ophthalmol. 2007; 52: 375–396
   PubMed Web of Science ®Google Scholar
• Tuft S J, Coster D J. The corneal endothelium. Eye 1990; 4: 389–424, (Pt. 3)
   PubMed Web of Science ®Google Scholar
• Boisgerault F, Liu Y, Anosova N, Ehrlich E, Dana M R, Benichou G. Role of CD4+ and CD8+ T cells in allorecognition: Lessons from corneal transplantation. J Immunol. 2001; 167: 1891–1899
   PubMed Web of Science ®Google Scholar
• Sano Y, Ksander B R, Streilein J W. Minor H, rather than MHC, alloantigens offer the greater barrier to successful orthotopic corneal transplantation in mice. Transpl Immunol. 1996; 4: 53–56
   PubMedGoogle Scholar
• Sano Y, Ksander B R, Streilein J W. Langerhans cells, orthotopic corneal allografts, and direct and indirect pathways of T-cell allorecognition. Invest Ophthalmol Vis Sci. 2000; 41: 1422–1431
   PubMed Web of Science ®Google Scholar
• Sano Y, Streilein J W, Ksander B R. Detection of minor alloantigen-specific cytotoxic T cells after rejection of murine orthotopic corneal allografts: Evidence that graft antigens are recognized exclusively via the “indirect pathway.”. Transplantation 1999; 68: 963–970
   PubMed Web of Science ®Google Scholar